Amish Research Clinic

Lancaster, Pennsylvania 17602

2 studies enrolling now · 8 studies all time

What they study most

Artery Occlusion, Aspirin Sensitivity, Cardiovascular Diseases, Clopidogrel, Poor Metabolism of, Coronary Artery Disease, Coronary Disease, Coronary Heart Disease, Diabetes, Diabetes Type 2, Heart Diseases, Hyperglycemia, Metabolism of Clopidogrel

Studies at this site

• Pharmacogenetics of Response to GLP1R Agonists — Recruiting now
• Effect of Zinc on Glucose Homeostasis — Recruiting now
• CES1 Carriers in the PAPI Study — Completed
• CES1 Crossover Trial of Clopidogrel and Ticagrelor — Completed
• Pharmacogenomics of GLP1 Receptor Agonists — Stopped early
• Clopidogrel Pharmacogenetics (PGX) Bench to Bedside — Completed
• Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study) — Completed
• Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes — Completed